An overview of thrombotic complications of old and new anticancer drugs

Thrombosis is a common complication of cancer with a mean prevalence of 15%. Most commonly, this presents as venous thromboembolism; however, other manifestations such as arterial thrombosis or thrombotic microangiopathy may occur. Cancer itself is not only associated with risk factors for thromboti...

Celý popis

Podrobná bibliografie

Vydáno v:	Thrombosis research Ročník 191; s. S17 - S21
Hlavní autoři:	Levi, Marcel, Sivapalaratnam, Suthesh
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States Elsevier Ltd 01.07.2020
Témata:	Anti-VEGF treatment Cancer Chemotherapy Endothelium Hematology, Oncology, and Palliative Medicine Thrombosis Thrombotic microangiopathy Thrombotic microangiopathy Anti-VEGF treatment Chemotherapy Thrombosis Cancer Endothelium
ISSN:	0049-3848, 1879-2472, 1879-2472
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!